ClinicalTrials.Veeva

Menu

Motor and Cognitive Functions in Acquired and Developmental Brain Damaged Patients

C

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Status

Unknown

Conditions

Perceptual Disorders
Cerebral Palsy
Hemiparesis

Treatments

Behavioral: Motor, cognitive and neuropsychological assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT02543424
2015/10FEV/053

Details and patient eligibility

About

Neurological pathologies cause important and permanent disabilities in every day life. These pathologies can follow stoke, affecting two people per one thousand each year or cerebral palsy, affecting two births per one thousand each year. To date, the diagnosis and the rehabilitation of motor and cognitive problems has been carried out separately by different domains. For example, physiotherapists have focused on motor problems and neuropsychologists have focused on cognitive functions. However, a number of studies have demonstrated a link between motor and cognitive abilities in adults and children. The present study has three main aims: (1) to better evaluate motor and cognitive problems in brain damaged patients (all ages), (2) to understand the link between motor and cognitive abilities in patients and healthy participants and, (3) to propose new types of therapies based on the link between motor and cognitive functions.

Enrollment

400 estimated patients

Sex

All

Ages

5+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Congenital cerebral palsy and acquired brain injury children and adult patients
  • Presenting upper limb paresis and/or hemineglect
  • Between the age of 3 to 90.
  • Able to understand and carry out simple verbal instruction

Exclusion criteria

  • IQ < 70
  • Severe aphasia, attentional disorder or psychiatric disorders
  • Neurodegenerative disorders

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

Patient group
Experimental group
Description:
Brain damaged adults with either hemiparesis and/or hemineglect. Brain damaged children with developmental and/or acquired disease inducing hemiparesis and/or hemineglect.
Treatment:
Behavioral: Motor, cognitive and neuropsychological assessment
Control group
Sham Comparator group
Description:
Healthy adults and children.
Treatment:
Behavioral: Motor, cognitive and neuropsychological assessment

Trial contacts and locations

2

Loading...

Central trial contact

Marie Alsamour; Stéphanie Dehem

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems